XSHE301009
Market cap362mUSD
Jan 07, Last price
9.89CNY
1D
3.24%
1Q
9.77%
IPO
-62.31%
Name
Hangzhou Coco Healthcare Products Co Ltd
Chart & Performance
P/E
131.56
P/S
2.46
EPS
0.08
Div Yield, %
0.00%
Shrs. gr., 5y
7.71%
Rev. gr., 5y
3.60%
Revenues
1.08b
-8.83%
Net income
20m
CFO
228m
Dividend
Jul 19, 20240.075 CNY/sh
Profile
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as absorbent towels and absorbent pads for men. The company was formerly known as Hangzhou Qiaozi Paper Industry Co.,Ltd. and changed its name to Hangzhou Coco Healthcare Products Co.,Ltd. in December 2011. Hangzhou Coco Healthcare Products Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 1,081,484 -8.83% | 1,186,290 -0.01% | |||||
Cost of revenue | 1,056,496 | 1,187,708 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 24,989 | (1,419) | |||||
NOPBT Margin | 2.31% | ||||||
Operating Taxes | 1,691 | ||||||
Tax Rate | 6.77% | ||||||
NOPAT | 23,298 | (1,419) | |||||
Net income | 20,185 | ||||||
Dividends | (19,030) | ||||||
Dividend yield | 0.58% | ||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | 1,450 | 1,353 | |||||
Long-term debt | 23,769 | 6,574 | |||||
Deferred revenue | 45,216 | 39,052 | |||||
Other long-term liabilities | 39,052 | ||||||
Net debt | (847,544) | (702,992) | |||||
| Cash flow | |||||||
Cash from operating activities | 227,703 | ||||||
CAPEX | (66,009) | ||||||
Cash from investing activities | (73,247) | ||||||
Cash from financing activities | 397 | (49,870) | |||||
FCF | 30,341 | 23,010 | |||||
| Balance | |||||||
Cash | 863,062 | 689,463 | |||||
Long term investments | 9,702 | 21,456 | |||||
Excess cash | 818,689 | 651,605 | |||||
Stockholders' equity | 726,370 | 708,511 | |||||
Invested Capital | 783,124 | 856,347 | |||||
ROIC | 2.84% | ||||||
ROCE | 1.66% | ||||||
| EV | |||||||
Common stock shares outstanding | 288,356 | 271,860 | |||||
Price | 10.66 -11.17% | 12.00 -34.96% | |||||
Market cap | 3,073,874 -5.78% | 3,262,320 -34.96% | |||||
EV | 2,303,205 | 2,638,526 | |||||
EBITDA | 81,828 | 59,834 | |||||
EV/EBITDA | 28.15 | 44.10 | |||||
Interest | 1,423 | 276 | |||||
Interest/NOPBT | 5.69% | ||||||